To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Arms Length Body Publication (In development)
NICE

Jun. 11 2024

Source Page: Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma [ID2725]
Publication Type: Invitation to participate
Document: Final stakeholder list PDF 182 KB (webpage)

Found: Company • AstraZeneca (d urvalumab , tremelimumab ) Patient/carer groups • Addenbrookes Liver


Scottish Government Publication (FOI/EIR release)
Chief Operating Officer, NHS Scotland Directorate

Sep. 09 2024

Source Page: Communications regarding cancer strategy: FOI Review
Document: FOI 202300373742 - Information Released - Annex C (PDF)

Found: liver cancer.


Arms Length Body Publication (Guidance)
NHS England

Jun. 26 2024

Source Page: Hepatocellular carcinoma surveillance
Document: Hepatocellular carcinoma surveillance: minimum standards (webpage)

Found: all liver cancers.


Deposited Papers

Oct. 06 2008

Source Page: Alcohol-attributable fractions for England: alcohol-attributable mortality and hospital admissions. 64 p.
Document: DEP2008-2282.pdf (PDF)

Found: Unspecified liver cirrhosis 69 Alcoholic liver disease 388 Alcoholic liver disease 167 Malignant neoplasm


Written Question
Liver Diseases: Shropshire
Monday 13th May 2024

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure there are effective pathways for early detection of liver disease in Shropshire.

Answered by Andrew Stephenson

Early detection of liver disease is vital to enable interventions, and encourage behavioural changes that can potentially lead to recovery. Liver disease is one of the primary risk factors for liver cancer. Across the Shropshire, Telford, and Wrekin Integrated Care Board (ICB) area, the early detection of liver disease is led by primary care partners, and the ICB encourages general practitioners to follow best practice in the delivery of patient care pathways, to ensure the early detection of liver disease in patients. The Shrewsbury and Telford Hospital NHS Trust is working with primary care partners to increase awareness and provide tools to support this work. The hospital also carries out active outreach into the community for drug and alcohol patients.


Deposited Papers

Jan. 10 2011

Source Page: Review of the support available to individuals infected with Hepatitis C and/or HIV by NHS supplied Blood Transfusions or Blood Products and their dependants. 70 p.
Document: DEP2011-0022.pdf (PDF)

Found: disease and liver cancer in the UK .


Arms Length Body Publication (In consultation)
NICE

Jul. 31 2024

Source Page: Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
Publication Type: Draft guidance: 1
Document: Committee papers PDF 5.64 MB (webpage)

Found: These health states are associated with increasingly poorer health outcomes as patients’ liver disease


Scottish Government Publication (FOI/EIR release)
Agriculture and Rural Economy Directorate

Aug. 29 2024

Source Page: Moredun Group and Preparing for Sustainable Farming (PSF): EIR release
Document: EIR 202400398892 - Information Released - Attachment (PDF)

Found: Cattle: liver fluke. Requires a liver fluke investigation, including flukicide efficacy testing .


Written Question
Liver Diseases: Women
Tuesday 14th May 2024

Asked by: Sharon Hodgson (Labour - Washington and Gateshead South)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she has taken to tackle changes in the level of premature deaths caused by liver disease in women under 75 between 2001 and 2022.

Answered by Andrea Leadsom

Through the 2021 Drugs Strategy, we are making the largest ever single increase in drug and alcohol treatment and recovery funding, with £780 million of additional investment. Of this, £532 million is being invested to rebuild local authority commissioned drugs and alcohol treatment services in England. This is in addition to the funding invested through the Public Health Grant

By February 2024, the funding had enabled an additional 9,878 people to benefit from treatment for alcohol problems, where alcohol was their only substance misuse problem, and a further 6,258 people where, as well as their alcohol problems, they were also being treated for problems associated with non-opiate drug use.

Local authorities are responsible for understanding the drug and alcohol treatment needs of their local communities, and planning and commissioning services to meet that need, including ensuring women have good access to the most effective treatment. The Department supports them in doing this, with data and guidance.

The National Health Service’s piloting of early diagnosis and prevention through 19 community diagnostic hubs reached over 7000 people in 2022/23, and is identifying undiagnosed liver disease. The Community Liver Health Check pilot provides FibroScans in one-stop community clinics, where patients also have other investigations as required.

Beyond treatment and early diagnosis, we are committed to tackling alcohol harms, including reducing consumption levels, and in 2023 the Government introduced reforms to alcohol duty, meaning products are taxed directly in proportion to their alcohol content.


Deposited Papers

May. 28 2008

Source Page: Standards for local surveillance and follow up of hepatitis B and C. 67 p.
Document: DEP2008-1379.pdf (PDF)

Found: disease and liver cancer across much of the world.